Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Doxepin Hydrochloride, and when can generics launch?

Doxepin Hydrochloride is a drug marketed by Sun Pharm Inds, Par Pharm, Purepac Pharm, Teva Pharms, Wockhardt, Silarx, Pharm Assoc, Sandoz, Watson Labs, Quantum Pharmics, Mylan Pharms Inc, Actavis Elizabeth, Dava Pharms Inc, and New River. and is included in fifty-five NDAs.

The generic ingredient in DOXEPIN HYDROCHLORIDE is doxepin hydrochloride. There are seven drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the doxepin hydrochloride profile page.

Summary for Tradename: DOXEPIN HYDROCHLORIDE

Suppliers / Packagers: see list25
Bulk Api Vendors: see list42
Clinical Trials: see list989
Patent Applications: see list575
Formulation / Manufacturing:see details
Drug Prices:see details

Pharmacology for Tradename: DOXEPIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics
doxepin hydrochloride
CAPSULE;ORAL072375-001Mar 15, 1989DISCNNoNo► Subscribe► Subscribe
doxepin hydrochloride
CAPSULE;ORAL071562-001Mar 2, 1987DISCNNoNo► Subscribe► Subscribe
Watson Labs
doxepin hydrochloride
CAPSULE;ORAL071486-001Apr 30, 1987DISCNNoNo► Subscribe► Subscribe
Mylan Pharms Inc
doxepin hydrochloride
CAPSULE;ORAL070791-002May 13, 1986ABRXNoNo► Subscribe► Subscribe
Watson Labs
doxepin hydrochloride
CAPSULE;ORAL071485-001Apr 30, 1987DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus